Ipratropium Bromide And Albuterol Sulfate Solution
Product Images NDC 50090-1669

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ipratropium Bromide And Albuterol Sulfate (NDC 50090-1669). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

B5387e98-figure-01 (B5387e98 Figure 01)

FDA Label Image

B5387e98-figure-02 (B5387e98 Figure 02)

FDA Label Image

B5387e98-figure-03 (B5387e98 Figure 03)

This appears to be a medication description for a combination of Albuterol and Ipratropium called "Mimutoral Sulfote Inhalation Solution". The dosage and instructions for use are not provided in the given text.*

FDA Label Image

B5387e98-figure-04 (B5387e98 Figure 04)

This document outlines the adverse events that occurred in greater than 1% of at least one treatment group and where the combination treatment showed the highest percentage. The adverse events were experienced by patients across three different treatments: Albuterol, Ipratropium, and Ipratropium Bromide. The COSTART terms were used to categorize the adverse events.*

FDA Label Image

B5387e98-figure-05 (B5387e98 Figure 05)

FDA Label Image

B5387e98-figure-06 (B5387e98 Figure 06)

FDA Label Image

B5387e98-figure-07 (B5387e98 Figure 07)

FDA Label Image

B5387e98-figure-08 (B5387e98 Figure 08)

FDA Label Image

Label Image (Lbl500901669)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.